GLC DETERMINATION OF APRINDINE IN HUMAN PLASMA USING A NITROGEN-PHOSPHORUS FLAME-IONIZATION DETECTORNASH JF; CARMICHAEL RH.1980; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1980; VOL. 69; NO 9; PP. 1094-1096; BIBL. 4 REF.Article

BENOXAPROFEN, A NEW ANTI-INFLAMMATORY AGENT: PARTICLE-SIZE EFFECT ON DISSOLUTION RATE AND ORAL ABSORPTION IN HUMANSRIDOLFO AS; THOMPKINS L; BECHTOL LD et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 7; PP. 850-852; BIBL. 15 REF.Article

DETERMINATION OF FLUOXETINE AND NORFLUOXETINE IN PLASMA BY GAS CHROMATOGRAPHY WITH ELECTRON-CAPTURE DETECTIONNASH JF; BOPP RJ; CARMICHAEL RH et al.1982; CLINICAL CHEMISTRY; ISSN 0009-9147; USA; DA. 1982; VOL. 28; NO 10; PP. 2100-2102; BIBL. 3 REF.Article

THE EFFECT OF CRYSTAL SIZE ON THE BIOAVAILABILITY OF BENOXAPROFEN: STUDIES UTILIZING DEUTERIUM LABELED DRUGWOLEN RL; CARMICHAEL RH; RIDOLFO AS et al.1979; BIOMED. MASS SPECTROM.; GBR; DA. 1979; VOL. 6; NO 4; PP. 173-178; BIBL. 12 REF.Article